Literature DB >> 29502233

Combined trabeculotomy-trabeculectomy using the modified Safer Surgery System augmented with MMC: its long-term outcomes of glaucoma treatment in Asian children.

Cherng-Ru Hsu1, Yi-Hao Chen1, Ming-Cheng Tai1, Da-Wen Lu2.   

Abstract

BACKGROUND: This study aimed to study the long-term surgical outcomes of combined trabeculotomy-trabeculectomy (CTT) using the modified Safer Surgery System in treating childhood glaucoma at a tertiary medical center in Taiwan.
METHODS: Retrospective, consecutive, noncomparative case series. We retrospectively reviewed medical records of 42 pediatric patients (age 0-18 years) who had CTT performed on their 65 eyes using the modified Safer Surgery System. The study period spanned 18 years (from January 1, 1997, to December 31, 2014). We evaluated the outcome in terms of postoperative intraocular pressure (IOP), axial length growth, disc cupping reversal, and use of antiglaucoma medications. The surgical success was rated using the Kaplan-Meier survival analysis and based on the incidence of complications.
RESULTS: The mean follow-up period was 85.05 ± 32.17 months (range 14-200). After operation, IOP dropped significantly from 35.76 ± 9.44 mmHg (mean ± SD) to 16.18 ± 7.20 mmHg together with a significant reversal of optic disc cupping. Similarly, the use of antiglaucoma medications was also significantly reduced in number from 1.26 ± 0.50 to 0.43 ± 0.70. Most of the axial lengths of the eyes measured at the last follow-up visit showed growths within the average ± 2 SDs in comparison with the healthy, age-matched population. After surgery, the qualified success rate was 90.77% at the end of the first year, 90.77% at the second year, 87.64% at the fifth year, 84.51% at the 10th year, and 81.38% at the 15th year. No serious intraoperative or postoperative complications were found.
CONCLUSIONS: For Taiwanese children, the combined trabeculotomy-trabeculectomy using the modified Safer Surgery System offered an efficient and safe surgical option for treating glaucoma with long-term satisfactory control of IOP.

Entities:  

Keywords:  Childhood glaucoma; Combined trabeculotomy–trabeculectomy; Modified safer surgery system

Mesh:

Substances:

Year:  2018        PMID: 29502233     DOI: 10.1007/s00417-018-3941-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  31 in total

1.  Correlation of postoperative axial length growth and intraocular pressure in congenital glaucoma--a retrospective study in trabeculotomy and goniotomy.

Authors:  G Kiefer; O Schwenn; F Grehn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-12       Impact factor: 3.117

2.  Long-Term Outcomes of Trabeculectomy Augmented with Mitomycin C Undertaken within the First 2 Years of Life.

Authors:  Hari Jayaram; Richard Scawn; Francisco Pooley; Mark Chiang; Catey Bunce; Nicholas G Strouthidis; Peng Tee Khaw; Maria Papadopoulos
Journal:  Ophthalmology       Date:  2015-08-24       Impact factor: 12.079

3.  Correlation between surgical success rate and severity of congenital glaucoma.

Authors:  A Al-Hazmi; A Awad; J Zwaan; S A Al-Mesfer; I Al-Jadaan; A Al-Mohammed
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

Review 4.  Surgical interventions for primary congenital glaucoma.

Authors:  Deepta Ghate; Xue Wang
Journal:  Cochrane Database Syst Rev       Date:  2015-01-30

5.  Microsurgery in congenital glaucoma.

Authors:  H C Agarwal; N N Sood; B R Kalra; Y Dayal
Journal:  Indian J Ophthalmol       Date:  1983 Nov-Dec       Impact factor: 1.848

6.  Long-term results of surgery in childhood glaucoma.

Authors:  Ali Alsheikheh; Janine Klink; Thomas Klink; Heimo Steffen; Franz Grehn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02       Impact factor: 3.117

Review 7.  Paediatric aphakic glaucoma.

Authors:  Caitriona Kirwan; Michael O'Keefe
Journal:  Acta Ophthalmol Scand       Date:  2006-12

8.  Primary infantile glaucoma in an Australian population.

Authors:  Jane R MacKinnon; Antonio Giubilato; James E Elder; Jamie E Craig; David A Mackey
Journal:  Clin Exp Ophthalmol       Date:  2004-02       Impact factor: 4.207

9.  Causes of visual impairment in children: a study of 3,210 cases.

Authors:  Maria Aparecida Onuki Haddad; Mayumi Sei; Marcos Wilson Sampaio; Newton Kara-José
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2007 Jul-Aug       Impact factor: 1.402

Review 10.  Review on the Management of Primary Congenital Glaucoma.

Authors:  Julia Yan Yu Chan; Bonnie Nk Choy; Alex Lk Ng; Jennifer Wh Shum
Journal:  J Curr Glaucoma Pract       Date:  2016-02-02
View more
  5 in total

1.  ZD6474 attenuates TGF-β1-induced fibrosis in human Tenon fibroblasts and inhibits neovascularization via AKT-mTOR signaling pathway.

Authors:  Wenting Liu; Yaying Chen; Xiangyuan Song; Yiwen Xue; Yuyan Zhang
Journal:  Int Ophthalmol       Date:  2022-10-13       Impact factor: 2.029

2.  Combined trabeculotomy-trabeculectomy with and without augmentation in primary congenital glaucoma: triple-armed randomized controlled trial.

Authors:  Marwa A Khairy; Said Kenawy; Khaled Mohamed Fawzi; Haitham Y Al-Nashar
Journal:  Int Ophthalmol       Date:  2022-10-20       Impact factor: 2.029

3.  Retrospective analysis of paediatric glaucoma at a tertiary referral centre in Hong Kong.

Authors:  Jonathan Cheuk-Hung Chan; Shing Chuen Chow; Jimmy Shiu-Ming Lai
Journal:  Jpn J Ophthalmol       Date:  2020-10-26       Impact factor: 2.447

4.  Trabeculotomy versus combined trabeculotomy-trabeculectomy for primary congenital glaucoma: study protocol of a randomised controlled trial.

Authors:  Lei Fang; Xinxing Guo; Yangfan Yang; Jian Zhang; Xiangxi Chen; Yingting Zhu; Jielei Huang; Jingjing Huang; Yimin Zhong; Xiaoyu Xu; Xing Liu
Journal:  BMJ Open       Date:  2020-02-25       Impact factor: 2.692

5.  Clinical Analysis of Pediatric Glaucoma in Central China.

Authors:  Qian Liu; Changgeng Liu; Haijun Li; Xiaoyuan Yang; Yangzeng Dong; Xiaomei Feng; Wenjun Cheng
Journal:  Front Med (Lausanne)       Date:  2022-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.